SYK240920P390000
- 26.60
- 0.000.00%
Stryker Corp Newsroom
Stryker Insider Sold Shares Worth $3,480,956, According to a Recent SEC Filing
Press Release: Stryker Completes Acquisition of Care.ai
Stryker Completes Acquisition Of Care.Ai >SYK
Express News | Stryker Completes Acquisition of Care.ai
Here's Why We Think Stryker (NYSE:SYK) Is Well Worth Watching
Slowing Rates Of Return At Stryker (NYSE:SYK) Leave Little Room For Excitement
Wells Fargo Maintains Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $381
Wells Fargo analyst Larry Biegelsen maintains $Stryker Corp(SYK.US)$ with a buy rating, and sets the target price at $381.According to TipRanks data, the analyst has a success rate of 62.6% and a
Express News | Eko Health Announces Appointment of Brent Lang, Former CEO of Vocera, to Board of Directors
Press Release: Eko Health Announces Appointment of Brent Lang, Former CEO of Vocera, to Board of Directors
Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80
US stocks gold rush | or become the biggest winner of the election debate! First Solar surged 15%; Is the wave of production cuts coming? The stock prices of two major lithium mining companies soared by more than 10% in response.
IBM's cloud computing business is strong, with its stock price hitting a new historical high, and has risen over 20% this year; business growth is benefiting from AI engines, with AppLovin's daily increase of 13.15%.
Stryker Adds Two Products to Foot, Ankle Portfolio
Here's How Much You Would Have Made Owning Stryker Stock In The Last 15 Years
Piper Sandler Maintains Overweight on Stryker, Maintains $380 Price Target
Piper Sandler Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $380
Piper Sandler analyst Matthew O'Brien maintains $Stryker Corp(SYK.US)$ with a buy rating, and maintains the target price at $380.According to TipRanks data, the analyst has a success rate of 51.1%
US stocks | Included in the s&p 500 index! AI stock Palantir soared more than 14% overnight; New drug efficacy beats merck! Biopharmaceutical company SMMT surged 56% in response.
The medical devices giants hit a new record high, with Boston Scientific up 1.29% overnight; Mastercard rose 2.3% overnight, reaching another all-time high.
Wolfe Initiates Stryker at Outperform With $405 Price Target
Wolfe Research Initiates Stryker Corp(SYK.US) With Buy Rating, Announces Target Price $405
Wolfe Research analyst Michael Polark initiates coverage on $Stryker Corp(SYK.US)$ with a buy rating, and sets the target price at $405.According to TipRanks data, the analyst has a success rate of 50
Stryker Corporation (SYK) Wells Fargo 2024 Healthcare Conference (Transcript)
Are Robust Financials Driving The Recent Rally In Stryker Corporation's (NYSE:SYK) Stock?